Patient Stories

Meet Afib patients who have undergone successful catheter ablation procedures after drug therapy failed or was ineffective. Watch and read their stories to learn how catheter ablation changed their lives. This safe treatment for Afib helped them regain the quality of life they thought was gone forever.

Meet Donne and Jan:

The couple diagnosed with Afib. After a few small strokes, Jan was diagnosed with Afib. Later, her husband Donne was also diagnosed with Afib. Watch to learn how this couple treated their hearts with radiofrequency catheter ablation.

“I had no idea that my increased fatigue was something more serious.”

- Ken S.

Active retiree

A retired executive running for political office, Ken thought his elevated fatigue was normal. He was diagnosed... Read More

Meet Rusty:

After being a pilot for 40 years, Rusty was suddenly grounded when he was diagnosed with Afib. Watch this video to learn how catheter ablation cleared Rusty to return to his passion, flying planes.

“It kind of feels like a panic attack. I was short of breath and dizzy.”

- Sue H.

Senior with heart conditions

Sue H., 69, and her husband were in the middle of a stressful move and in between homes when she started experiencing heart flutters... Read More

Meet Neleta:

A widow who treated her Afib with catheter ablation. Afib caused Neleta to feel tired, short of breath, and weak, preventing her from performing simple tasks such as taking out the trash and doing the dishes... . Drug therapy wasn't effective for Neleta, so she turned to catheter ablation to treat her Afib. After her catheter ablation procedure, Neleta felt a renewed sense of energy, had more confidence, and was comfortable traveling again. Watch Neleta's story to learn more. Read More

“The most disruptive feeling was knowing I had an irregular heartbeat and constantly wondering what it meant long term for my life, my health and my career.”

- Tim K.

Family man and airline pilot

Tim chose catheter ablation to treat his irregular heartbeat after his medication left him feeling tired and did not fully correct his Afib. ... Read More

Remember, as with any medical treatment, individual results may vary. Only a cardiologist or electrophysiologist can determine whether ablation is an appropriate course of treatment. There are potential risks including bleeding, swelling or bruising at the catheter insertion site, and infection. More serious complications are rare, which can include damage to the heart or blood vessels; blood clots (which may lead to stroke); heart attack, or death. These risks need to be discussed with your doctor and recovery takes time.

Caution: US law restricts this device to sale by or on the order of a physician. Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.

The NAVISTAR® THERMOCOOL®, EZ STEER® THERMOCOOL® NAV, THERMOCOOL® SF NAV, and THERMOCOOL SMARTTOUCH® Catheters are FDA approved for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. Catheter ablation for AF may not be an option for you if you have any of the following conditions: certain recent heart surgery; prosthetic valves; active systemic infection; certain cancers; intracardiac thrombus, or an interatrial baffle or patch. Consult your physician to find out if catheter ablation is right for you.

As with any medical treatment, individual results may vary. Only a cardiologist or electrophysiologist can determine whether ablation is an appropriate course of treatment. There are potential risks including bleeding, swelling or bruising at the catheter insertion site, and infection. More serious complications are rare, which can include damage to the heart or blood vessels; blood clots (which may lead to stroke); heart attack, or death. These risks need to be discussed with your doctor and recovery takes time.

THERMOCOOL® Navigation Catheters are indicated for the treatment of recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults.